Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis
New England Journal of Medicine, 2018 · Multicenter (French, 29 sites), randomized controlled trial, stopped early for futility.
Clinical question
In patients with septic shock and severe (RIFLE 'Failure' stage) AKI, does early RRT initiation improve 90-day survival compared with a delayed strategy?
What the trial found
In patients with septic shock and severe AKI specifically, early RRT initiation did not improve 90-day survival compared with a delayed, indication-based strategy.
Current guideline position
Consistent with AKIKI and STARRT-AKI, and contributes to current practice favoring indication-based rather than stage-based RRT initiation timing, including in septic AKI specifically.
Clinical interpretation
IDEAL-ICU extends the AKIKI finding to a septic-shock-specific population and reinforces that routine early RRT does not improve survival even in this higher-acuity group — supporting watchful waiting with RRT reserved for a defined indication rather than initiated pre-emptively based on AKI stage alone.
Limitations
Sepsis-AKI microcirculatory decoupling, KDIGO staging, Furosemide Stress Test (FST), urine microscopy, and the AEIOU dialysis threshold framework.
Principles of convection vs diffusion, filtration fraction, delivered effluent dosing (20–25 mL/kg/h), Regional Citrate Anticoagulation, and citrate toxicity.
The subset of sepsis with profound circulatory and cellular/metabolic abnormality — clinically identified by a vasopressor requirement to maintain MAP ≥ 65 mmHg plus lactate > 2 mmol/L despite adequate fluid resuscitation.